Literature DB >> 32503704

ASE Statement on Point-of-Care Ultrasound during the 2019 Novel Coronavirus Pandemic.

Amer M Johri1, Benjamin Galen2, James N Kirkpatrick3, Michael Lanspa4, Sharon Mulvagh5, Ritu Thamman6.   

Abstract

Entities:  

Keywords:  COVID-19; Lung ultrasound; Point-of-care ultrasound

Mesh:

Year:  2020        PMID: 32503704      PMCID: PMC7158805          DOI: 10.1016/j.echo.2020.04.017

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


× No keyword cloud information.

Why Conduct Point-of-Care Ultrasound in Coronavirus Disease 2019 Infection?

Although lung injury is common in coronavirus disease 2019 (COVID-19) infection, myocardial injury may be present in more than a quarter of patients with critical disease. Thus the rapid, bedside assessment of the heart, chest, and vessels using point-of-care ultrasound (POCUS) has propelled this tool to the front lines of the fight against the COVID-19 pandemic. POCUS is usually conducted by the treating provider to obtain real-time information for management decisions. Cardiac views are frequently obtained, along with noncardiac views such as the chest (lung, pleura) and vessels (neck and leg veins, aorta). In infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in particular, POCUS may help triage patients with dyspnea and determine need for subsequent imaging (echocardiography, computed tomography, etc.). A modified version of the American Society of Echocardiography (ASE) POCUS protocol may be of value in suspected or confirmed COVID-19 infection (Figure 1 ). The base ASE POCUS protocol can be accessed free online at https://aseuniversity.org/ase/lessons/47.
Figure 1

ASE POCUS protocol imaging views in suspected or confirmed COVID-19. The ASE modified POCUS protocol includes basic cardiac views, subcostal views for inferior vena cava (IVC) and pericardial fluid, and chest views. This protocol may assist in the initial cardiopulmonary assessment of patients with COVID-19 if POCUS is deemed indicated.

ASE POCUS protocol imaging views in suspected or confirmed COVID-19. The ASE modified POCUS protocol includes basic cardiac views, subcostal views for inferior vena cava (IVC) and pericardial fluid, and chest views. This protocol may assist in the initial cardiopulmonary assessment of patients with COVID-19 if POCUS is deemed indicated.

Cardiac POCUS

A well-illustrated case series of the application of focused ultrasound in patients with severe COVID-19 and associated cardiovascular disease from Wuhan, China, was recently presented. Figure 2 lists cardiac POCUS findings and indications. Early reports suggest that cardiac POCUS indications in COVID-19 include the following:
Figure 2

ASE POCUS protocol in suspected or confirmed COVID-19 infection: modified POCUS protocol to assist in the assessment of patients with COVID-19 includes heart, chest, and vessel views.

Detection or characterization of preexisting cardiovascular disease. Early identification of worsening cardiac function, either due to known preexisting disease or associated with the infection. Monitoring and examination: POCUS may be able to assess changes in cardiac function over time through quick routine examinations, perhaps in lieu of heart and lung auscultation, which can be challenging in critical care settings because of pronation, ambient noise, and personal protective equipment (PPE). Elucidation of cardiovascular abnormalities potentially associated with COVID-19: Early reports suggest that some patients develop pericardial effusion and/or myocarditis that can progress to shock. A hypercoagulable state may be associated, leading to deep vein thrombosis and pulmonary embolism with associated right ventricular findings and acute pulmonary hypertension. Left ventricular systolic dysfunction, either global or regional, may be associated with myocarditis, a stress-induced cardiomyopathy pattern, or epicardial or microvascular coronary thrombosis. ASE POCUS protocol in suspected or confirmed COVID-19 infection: modified POCUS protocol to assist in the assessment of patients with COVID-19 includes heart, chest, and vessel views.

Lung POCUS

When radiographic studies such as computed tomography might be limited, lung POCUS can be used to trend the severity of COVID-19 pneumonia as an adjunct to oximetry and physical examination. Lung and vascular POCUS applications in COVID-19 are listed in Figure 2. Characteristic lung findings in preliminary publications are consistent with a viral pneumonia: a thickened and irregular pleural line and scattered B-lines (mild disease). In severe disease, this can progress to confluent B-lines with pulmonary consolidation, including air bronchograms. POCUS is useful to exclude other chest pathologies in critically ill patients, such as pneumothorax (particularly in patients on positive pressure ventilation) and symptomatic large pleural effusion. Vascular POCUS for procedural guidance and access is well established in acute settings. Assessment of the inferior vena cava and/or jugular venous pulsation plays an important role in the hemodynamic assessment of critically ill patients to enhance the physical examination and in the assessment of fluid status. Deep vein thrombosis risk increases with any critically ill bedbound patient; moreover, early reports indicate an association between COVID-19 and a prothrombotic state. A unilateral deep vein thrombosis study performed by a sonographer is relatively quick and focused. However, in case a sonographer is not available, and in context of the pandemic, the two-point compression POCUS technique may be considered by practitioners trained in the technique.

When to Perform POCUS in COVID-19?

Not all patients with COVID-19 require a POCUS examination. However, if cardiac and chest ultrasound is indicated, some institutions may choose POCUS as the first-line application of ultrasound. Deterioration in clinical status may then trigger a more extensive examination, such as a limited transthoracic echocardiography (TTE) guided by the POCUS images. The primary advantage of using POCUS first in a patient with COVID-19 is reduction of exposure to other personnel and locations, permitting conservation of PPE. Disadvantages include potentially poorer imaging resolution compared with systems used for comprehensive TTE, missed findings, operator inexperience, archiving issues, and inability to immediately convert the POCUS study to a comprehensive examination if needed. A work-flow algorithm for patients with COVID-19 in whom further cardiopulmonary ultrasound is indicated is provided in Figure 3 . If POCUS examination is available, and the scan sufficiently answers the clinical question, then the need for subsequent TTE may be obviated. If the POCUS scan is insufficient, or reveals findings requiring comprehensive evaluation, TTE may be considered appropriate. Limited TTE can be planned and guided by the POCUS findings to minimize sonographer exposure. In some instances, POCUS may be insufficient to exclude a suspected cardiac abnormality, for example, in the case of difficult image acquisition, and it may be more efficient for a skilled sonographer to rapidly scan the patient, rather than have a POCUS operator struggle with prolonged attempts. Judicious use of ultrasound must be considered to avoid unnecessary exposure of personnel to contagion and conserve the use of limited resources such as PPE. Caution must be exercised to ensure that the suggested POCUS work-flow algorithm is not increasing the utilization of unnecessary or inappropriate TTE.
Figure 3

POCUS work flow in suspected or confirmed COVID-19. Potential work flow for POCUS during the COVID-19 pandemic, in the instance that cardiopulmonary ultrasound is indicated. If available, and there is suspicion of cardiopulmonary abnormality requiring further evaluation, POCUS can be the first-line ultrasound examination performed. If the POCUS performed by a trained operator is sufficient to either exclude or define the cardiopulmonary abnormality, further TTE may not be required. If the POCUS is insufficient, limited or comprehensive TTE may be considered as appropriate.

POCUS work flow in suspected or confirmed COVID-19. Potential work flow for POCUS during the COVID-19 pandemic, in the instance that cardiopulmonary ultrasound is indicated. If available, and there is suspicion of cardiopulmonary abnormality requiring further evaluation, POCUS can be the first-line ultrasound examination performed. If the POCUS performed by a trained operator is sufficient to either exclude or define the cardiopulmonary abnormality, further TTE may not be required. If the POCUS is insufficient, limited or comprehensive TTE may be considered as appropriate.

How to Perform POCUS in COVID-19?

Safety and Cleaning

PPE implementation for sonographers and machine cleaning principles are described in the parent document to this supplement and apply to POCUS. Because of the size and flexibility of POCUS devices, institutions may decide to dedicate these devices to a fixed location, such as an isolated COVID-19 unit, with meticulous cleaning between patient examinations and at the end of each day in a dedicated cleaning storage facility within the unit. The suggestions for scanning and cleaning are summarized in Table 1 (modified from the American College of Emergency Physicians). This is a suggested checklist, but specific steps, procedures, and their order may vary depending upon institutional guidance, the care environment, and the management pathway. It is important to recognize that institutions may develop their own protocols for decontamination and that these should be posted clearly. Additional information on transducer cleaning can be found on the American Institute of Ultrasound in Medicine website.
Table 1

Example POCUS device cleaning checklist in suspected or confirmed COVID-19

1Review PPE precautionsPlan scans to minimize time and riskRemove excess items from machine before entering roomMask patient (institution specific)
2After scan: inspect and wipe probe/device wearing PPE
3Initial cleaning in patient's room
4Push machine out of room while doffing gownSanitize hands, new gloves, keep mask and face shield on
5Reinspect machine and perform low-level disinfection cleaning with appropriate agent using product recommended wet time (usually 2 min), allow dry timeRemove other PPERemove gloves, sanitize hands againRecord personnel, document scan
Other considerations
6Consider using aliquot or single-use gel packets
7Consider probe/device covers (institution specific)
8Consider dedicating machine to unit (institution specific)
9Hold in-service for users, share knowledge
10Periodically review institutional and society guidance
Example POCUS device cleaning checklist in suspected or confirmed COVID-19

Archiving and Storage

Given the potential for deterioration in patients with COVID-19, every attempt should be made to store, archive, and document POCUS results to allow image comparison. This helps reduce the need for repeat scans that would impinge upon scarce PPE resources and the risk for exposure. At the very least, results should be documented in the physical examination or investigations section of the patient's chart.

Who Should Perform POCUS?

All POCUS practitioners should operate within their skill sets as described by the ASE recommendations for echocardiography laboratories participating in POCUS and critical care echocardiography training. Some users may have POCUS credentials from societies such as the American College of Chest Physicians and/or the Society for Hospital Medicine. Many institutions have planned for the possibility of a tiered response to the crisis, as proposed by the Society of Critical Care Medicine. In such a response, nonintensivist physicians might be directly managing patients with COVID-19. Novice practitioners may be recruited to use POCUS in the midst of a surge of patients. These individuals should receive proper training, but the usual modes of teaching by practicing on patients are currently inadvisable. Simulators are an approach to introduce POCUS image acquisition and interpretation. Several online modules are available that offer an ability to learn background knowledge, such as the ASE modules and introductory lung modules available at PocusJournal.com. To enhance training and enable access to experts, commercially available platforms now exist that use interactive teleconsultative tools for remote guidance and supervision.

Summary

When cardiopulmonary ultrasound is indicated in a patient with COVID-19, POCUS may be considered the first-line ultrasound examination performed, which then guides the need for further imaging. This approach may help conserve personnel and PPE, as well as limit exposure to other personnel and locations. Given the potential for rapid clinical deterioration in patients with COVID-19, every attempt should be made to store and document POCUS results to reduce the need for repeat examination. Meticulous cleaning of any POCUS device is critical to reduce the risk for SARS-CoV-2 transmission. POCUS must be performed by individuals with the correct skill set, an understanding of the limitations of this technology, and meticulous attention to PPE and machine cleaning.
  2 in total

1.  Recommendations for Echocardiography Laboratories Participating in Cardiac Point of Care Cardiac Ultrasound (POCUS) and Critical Care Echocardiography Training: Report from the American Society of Echocardiography.

Authors:  James N Kirkpatrick; Richard Grimm; Amer M Johri; Bruce J Kimura; Smadar Kort; Arthur J Labovitz; Michael Lanspa; Sue Phillip; Samreen Raza; Kelly Thorson; Joel Turner
Journal:  J Am Soc Echocardiogr       Date:  2020-02-29       Impact factor: 5.251

2.  Comparison of 2-point and 3-point point-of-care ultrasound techniques for deep vein thrombosis at the emergency department: A meta-analysis.

Authors:  Ju Hyung Lee; Sun Hwa Lee; Seong Jong Yun
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  2 in total
  48 in total

Review 1.  Clinical Progress Note: Point-of-Care Ultrasound Applications in COVID-19.

Authors:  Benji K Mathews; Seth Koenig; Linda Kurian; Benjamin Galen; Gregory Mints; Gigi Liu; Nilam J Soni
Journal:  J Hosp Med       Date:  2020-06       Impact factor: 2.960

2.  Joint Guideline on Venous Thromboembolism - 2022.

Authors:  Ana Cristina Lopes Albricker; Cláudia Maria Vilas Freire; Simone Nascimento Dos Santos; Monica Luiza de Alcantara; Mohamed Hassan Saleh; Armando Luis Cantisano; José Aldo Ribeiro Teodoro; Carmen Lucia Lascasas Porto; Salomon Israel do Amaral; Orlando Carlos Gloria Veloso; Ana Cláudia Gomes Pereira Petisco; Fanilda Souto Barros; Márcio Vinícius Lins de Barros; Adriano José de Souza; Marcone Lima Sobreira; Robson Barbosa de Miranda; Domingos de Moraes; Carlos Gustavo Yuji Verrastro; Alexandre Dias Mançano; Ronaldo de Souza Leão Lima; Valdair Francisco Muglia; Cristina Sebastião Matushita; Rafael Willain Lopes; Artur Martins Novaes Coutinho; Diego Bromfman Pianta; Alair Augusto Sarmet Moreira Damas Dos Santos; Bruno de Lima Naves; Marcelo Luiz Campos Vieira; Carlos Eduardo Rochitte
Journal:  Arq Bras Cardiol       Date:  2022-04       Impact factor: 2.000

3.  The Role of Lung Ultrasound Monitoring in Early Detection of Ventilator-Associated Pneumonia in COVID-19 Patients: A Retrospective Observational Study.

Authors:  Silvia Mongodi; Nello De Vita; Giulia Salve; Silvia Bonaiti; Francesco Daverio; Margherita Cavagnino; Gilda Siano; Alessandro Amatu; Giuseppe Maggio; Valeria Musella; Catherine Klersy; Rosanna Vaschetto; Belaid Bouhemad; Francesco Mojoli
Journal:  J Clin Med       Date:  2022-05-26       Impact factor: 4.964

Review 4.  Coronavirus disease and the cardiovascular system: a narrative review of the mechanisms of injury and management implications.

Authors:  Maria Vega Brizneda; Agam Bansal; Vardhmaan Jain; Samir Kapadia; Lars G Svensson; Venu Menon; Paul Cremer; Grant Reed; Penelope Rampersad; Richard Grimm; Brian P Griffin; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 5.  Multimodality cardiac imaging in the 21st century: evolution, advances and future opportunities for innovation.

Authors:  Melissa A Daubert; Tina Tailor; Olga James; Leslee J Shaw; Pamela S Douglas; Lynne Koweek
Journal:  Br J Radiol       Date:  2020-11-25       Impact factor: 3.039

6.  Paradoxical venous air embolism detected with point-of-care ultrasound: a case report.

Authors:  Hector Andres Ruiz Avila; Hans Fred García-Araque; Estivalis Acosta-Gutiérrez
Journal:  Ultrasound J       Date:  2022-05-18

Review 7.  Multimodality Cardiovascular Imaging in the Midst of the COVID-19 Pandemic: Ramping Up Safely to a New Normal.

Authors:  William A Zoghbi; Marcelo F DiCarli; Ron Blankstein; Andrew D Choi; Vasken Dilsizian; Frank A Flachskampf; Jeffrey B Geske; Paul A Grayburn; Farouc A Jaffer; Raymond Y Kwong; Jonathan A Leipsic; Thomas H Marwick; Eike Nagel; Koen Nieman; Subha V Raman; Michael Salerno; Partho P Sengupta; Leslee J Shaw; Y S Chandrashekhar
Journal:  JACC Cardiovasc Imaging       Date:  2020-06-12

Review 8.  Utility of Non-invasive Cardiac Imaging Assessment in Coronavirus Disease 2019.

Authors:  Sandeep S Hothi; Jin Jiang; Richard P Steeds; William E Moody
Journal:  Front Cardiovasc Med       Date:  2021-05-21

9.  The role of lung ultrasound in COVID-19 disease.

Authors: 
Journal:  Insights Imaging       Date:  2021-06-19

10.  Lung Ultrasound for Cardiologists in the Time of COVID-19.

Authors:  Omid Kiamanesh; Lea Harper; Katie Wiskar; Warren Luksun; Michael McDonald; Heather Ross; Anna Woo; John Granton
Journal:  Can J Cardiol       Date:  2020-05-19       Impact factor: 6.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.